El proyecto “Desarrollo de una innovadora formulación farmacéutica de liberación dual para la reducción de las caídas y FOG en pacientes con enfermedad de Parkinson” con el número de expediente ZL-2025/00887 y el acrónimo PHARMA-PD, liderado por Golden Gait Biotech, ha sido financiado por el Programa de Ayudas de Apoyo a la I+D Empresarial – HAZITEK de Gobierno Vasco.
Esta actuación esta cofinanciada por el Gobierno Vasco y la Union Europea a través del Fondo Europeo de Desarrollo Regional 2021-2027 (FEDER).
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |